Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Eli Lilly Corp. | 75 | 0 | 12 | 0 | €820.10 | €831.01 | 1.330% |
| Vertex Pharmaceuticals Inc. | 59 | 2 | 2 | 0 | €428.15 | €450.36 | 5.188% |
| Regeneron Pharmaceuticals Inc. | 48 | 1 | 4 | 0 | €1,030.5 | €1,087.6 | 5.537% |
| Insmed Inc. | 46 | 0 | 2 | 0 | €67.00 | €77.15 | 15.149% |
| Alnylam Pharmace. | 45 | 0 | 5 | 0 | €247.60 | €275.25 | 11.167% |
| Neurocrine Bioscience | 42 | 0 | 4 | 0 | €107.90 | €155.89 | 44.476% |
| Johnson & Johnson | 40 | 1 | 4 | 0 | €147.68 | €193.85 | 31.267% |
| Intra-Cellular Therapies Inc. | 35 | 0 | 5 | 0 | €69.00 | €85.00 | 23.188% |
| Acadia Pharmaceuticals | 36 | 1 | 1 | 0 | €14.72 | €29.92 | 103.299% |
| AbbVie Inc. | 34 | 0 | 1 | 0 | €173.46 | €180.90 | 4.291% |
| Cytokinetics Inc. | 35 | 1 | 5 | 0 | €49.80 | €83.13 | 66.930% |
| Jazz Pharmaceuticals plc | 32 | 0 | 2 | 0 | €99.70 | €183.41 | 83.966% |
| Merck & Co. Inc. | 32 | 1 | 2 | 0 | €105.00 | €126.38 | 20.362% |
| BioMarin Pharmaceutical Inc. | 29 | 0 | 12 | 0 | €64.00 | €100.74 | 57.403% |
| Amgen Inc. | 27 | 0 | 0 | 0 | €301.00 | €304.82 | 1.269% |
| United Therapeutics | 28 | 1 | 3 | 0 | €315.00 | €323.16 | 2.589% |
| Ultragenyx Pharmaceutical Inc. | 28 | 1 | 3 | 0 | €52.50 | €84.74 | 61.417% |